Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Eliminating malaria in the Asia-Pacific could save 400,000 lives

Research

Increased funding is needed to eliminate malaria across 22 Asia-Pacific countries and save an estimated 400,000 lives, according to research published in a new collection of studies on Wellcome Open Research.

© MORU 2019. Photographer: Nicky Almasy
A Cambodian child teaches his classmates what he's learned about malaria control, part of MORU's activities to raise community awareness in malaria-endemic areas of the importance of malaria prevention and the importance of early treatment.

Although Asia-Pacific countries have made significant progress towards their goal of eliminating malaria by 2030, collection researchers warn that stagnating donor funding puts at risk national malaria control efforts and access to lifesaving drugs and other tools, and could, under one potential scenario, result in as many as 845 million more malaria cases and 3.5 million deaths.

“This evidence-based investment case for the region comes from preliminary estimates to quantify the economic benefits of eliminating malaria, which could save hundreds of thousands of lives, avoid millions of malaria cases, and generate billions in healthcare savings, as well as savings from lost wages and productivity due to illness.” said collection advisor and study author Prof Richard Maude from the Mahidol Oxford Tropical Medicine Research Unit (MORU) in Bangkok.

“While the cost of eliminating malaria in the Asia Pacific is not insignificant, it will result in a large return on investment. For every additional dollar spent, there was predicted to be an overall economic benefit of USD $6 for the affected countries,” said lead study author Rima Shretta.

Read more (Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine website)

Similar stories

Forecasting how best to control and eliminate Neglected Tropical Diseases

Neglected tropical diseases (NTDs) are a major cause of death, disability, and economic hardship worldwide, particularly in low- and middle-income countries. While many of these diseases are targeted for control, elimination, or eradication by 2030, achieving those targets will be challenging due to disruptions to programmes related to the COVID-19 pandemic and differences in disease transmission across regions, which requires tailoring interventions to local settings.

Novel inhaled TB vaccine

First-in-human vaccine trial for deadly Nipah virus launched

Malaria chemoprevention after hospital discharge reduced mortality and sickness in children recovering from severe anaemia

Early-life diseases linked to lifelong childlessness

Report sets out recommendations for reducing inequities and improving care for babies of Asian and Black mothers